2024 Revenue
$9.2M
Funding
$20M
YOY
66%
Team
39
Founded
2013
How CancerIQ CEO Feyi Ayodele grew to $9.2M revenue with a 39 person team in 2024.
Provider of a Web-based digital application designed to allow oncologists collect genetic information from cancer patients and compare that information against a large database of similar patients. The company's application helps patients and physicians to identify risk factors caused due to cancer, genetics and other oncological problem, enabling doctors to identify high-risk patients and offer preventative treatment.
Last updated
CancerIQ Revenue
In 2024, CancerIQ's revenue reached $9.2M. The company previously reported $5.5M in 2023. Since its launch in 2013, CancerIQ has shown consistent revenue growth.
| Year | Milestone | Quote |
|---|---|---|
| 2024 | CancerIQ Hit $9.2m revenue in October 2024 | |
| 2023 | CancerIQ Hit $5.5m revenue in November 2023 | |
| 2022 | CancerIQ Hit $4m revenue in November 2022 | |
| 2021 | CancerIQ Hit $1.7m revenue in November 2021 | |
| 2013 | Launched with $0 revenue |
CancerIQ Valuation, Funding Rounds
CancerIQ has not publicly disclosed its valuation. The company has raised $20M in total funding to date.
CancerIQ has raised $20M in total funding across 3 rounds, most recently a $14M Series B round in 2022.
| Year | Round | Amount | Valuation | % Sold | Quote |
|---|---|---|---|---|---|
| 2022 | Series B | $14M | - | - | |
| 2020 | Series A | $4.8M | - | - | |
| 2014 | Convertible Note | $1.2M | - | - |
Founder / CEO
Feyi Ayodele
CEO
Founder and CEO at Cancer IQ Inc. Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively. Her journey with Cancer IQ began in 2012, when Feyi wanted to be more of a participant in the healthcare sector than a bystander. On a family trip to climb Mount Kilimanjaro, she hatched a plan to defer her position at McKinsey and commercialize the work of her mother, a renowned medical oncologist. While at University of Chicago Medicine, Feyi witnessed the most cutting edge clinical care, and identified a number of bottlenecks that constrained patient access to it. In 2013, CancerIQ was born. After recruiting a board of thought leading advisors spearheaded by her mother, she led the product design effort, raised capital, and recruited a team to help her flesh-out the concept. Since conceiving the concept, CancerIQ has garnered support from top accelerator programs, investors, and most importantly - customers. She leads the business development team at CancerIQ, and manages all strategic partnerships. She is a Chicago Booth New Venture Challenge winner, a Rock Health fellow, and winner of 1776’s Global Challenge Cup.
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
We do not have customer count information for CancerIQ yet.
CancerIQ Employees & Team Size
CancerIQ employs approximately 39 people as of 2026, down from 46 in 2023, including 9 sales reps that carry a quota.
| Year | Milestone |
|---|---|
| 2024 | Reached 39 employees (December 2024) |
| 2024 | Reached 37 employees (October 2024) |
| 2023 | Reached 46 employees (November 2023) |
| 2022 | Reached 33 employees (November 2022) |
| 2022 | Reached 33 employees (March 2022) |
| 2021 | Reached 20 employees (November 2021) |
| 2021 | Reached 20 employees (April 2021) |
| 2020 | Reached 18 employees (November 2020) |
Frequently Asked Questions about CancerIQ
What is CancerIQ's revenue?
CancerIQ generates an estimated $9.2M in annual revenue.
Who founded CancerIQ?
CancerIQ was founded by Feyi Ayodele.
Who is the CEO of CancerIQ?
The CEO of CancerIQ is Feyi Ayodele.
How much funding does CancerIQ have?
CancerIQ raised $20M across 3 rounds.
How many employees does CancerIQ have?
CancerIQ has 39 employees.
Where is CancerIQ headquarters?
CancerIQ is headquartered in United States.
Compare CancerIQ to the industry
CancerIQ operates across multiple industries. Browse revenue, funding, and growth data for CancerIQ in each sector below.
Data and Sources
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profilePeople Also Viewed
Qobra
Qobra is an AI-first sales compensation platform founded in 2020 by Antoine Fort (CEO), Axel (CTO), and Tongue (CPO). The company automates end-to-end commissions, replacing spreadsheet-based workflows for sales organizations. Fort co-founded the business almost immediately after graduating, drawing on relationships with senior sales leaders to understand the problem rather than personal experience as a commission-earner. Qobra has grown from a 100K pre-seed round and its first customer in 2020 to approximately 8M in ARR as of May 2026, serving more than 250 customers at an average ACV of roughly 30,000 per year. The company broke 1M ARR in 2022, reached between 4M and 5M ARR twelve months prior to the interview, and is targeting 10M ARR by end of 2026. Total funding raised stands at 5.7M across a 111K pre-seed in 2020 and a 5.5M seed in 2022, supplemented by a 10M Series A in late 2023 and 2M in debt financing. Investors include Singular and Brieger. The team has grown to 49 people. The single most interesting strategic inflection point is Qobra's bet that AI agents will allow it to capture dollars currently flowing to implementation consultants and external firms. The company is launching three agents, called the Analyst, the Architect, and the Coach, in June 2026, with the Architect able to build and deploy compensation plans in minutes instead of weeks. Fort frames this as turning a 6-dollar services market into software revenue, citing Sequoia's thesis that for every dollar spent on software, six dollars are spent on services.
Chattermill Analytics
Copilot transforms the way you interact with your customer data. With the power of generative AI, you can get answers to all of your CX, product, and marketing questions, improving team alignment, efficiency, and productivity. Have questions? Just ask!
Bevywise Networks
An end to end product & solution provider for your IoT & IIoT requriement. MQTT Broker, IoT Simulator and IoT Platform are the key products.
Tera
Tera is a AI powered smarter finance platform offering unified experience for businesses
Teneo.ai
The only Agentic AI Platform proven with real customers—automating +60% of interactions with 99% voice accuracy.
Astra Security
Astra Security is a privately held U.S. & India based cyber security company. Backed by Techstars, Astra offers a Pentest Platform that helps organizations become proactively secure. The Pentest Platform uncovers more than 30,000+ vulnerabilities for its customers every month, saving its customers millions of dollars in potential loss and thousands of developer hours. The company has earned several accolades including ‘The Most Innovative Security Company’ by Prime Minister Narendra Modi at the Global Conference on Cyber Security (2017), one of the top 50 emerging cybersecurity companies at ‘Emerge 50’ by NASSCOM, the French Tech Ticket under which Astra Security got rewarded by the President of France under the La French Tech program. In 2021, Astra Security was also named as a CyberTech100 company. Astra is a trusted security partner to some of the well-known brands like Muthoot Finance, NIIT, Goldcast, ITC & more. Our flagship product, ASTRA, brings together an extensive feature set of manual/automated penetration testing tools, while performing a comprehensive vulnerability assessment and proactively responds to threats.
